Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity
- PMID: 10768093
- DOI: 10.1007/s001250050050
Natural variants of human p85 alpha phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity
Abstract
Aims/hypothesis: Phosphoinositide 3-kinase (PI 3K) plays a central part in the mediation of insulin-stimulated glucose disposal. No genetic studies of this enzyme in human syndromes of severe insulin resistance have been previously reported.
Methods: Phosphoinositide 3-kinase p85 alpha regulatory subunit cDNA was examined in 20 subjects with syndromes of severe insulin resistance by single strand conformational polymorphism and restriction fragment length polymorphism analyses. Insulin-stimulated phosphoinositide 3-kinase activity and recruitment into phosphotyrosine complexes of variants of p85 alpha were studied in transiently transfected HEK293 cells. Phosphopeptide binding characteristics of wild-type and mutant p85 alpha-GST fusion proteins were examined by surface plasmon resonance.
Results: The common p85 alpha variant, Met326I1e, was identified in 9 of the 20 subjects. Functional studies of the Met326Ile variant showed it to have equivalent insulin-stimulated lipid kinase activity and phosphotyrosine recruitment as wild-type p85 alpha. A novel heterozygous mutation, Arg409Gln, was detected in one subject. Within the proband's family, carriers of the mutation had a higher median fasting plasma insulin (218 pmol/l) compared with wild-type relatives (72 mol/l) (n = 8 subjects, p = 0.06). The Arg409Gln p85 alpha subunit was associated with lower insulin-stimulated phosphoinositide 3-kinase activity compared with wild-type (mean reduction 15%, p < 0.05, n = 5). The recruitment of Arg409Gln p85 alpha into phosphotyrosine complexes was not significantly impaired. GST fusion proteins of wild-type and mutant p85 alpha showed identical binding to phosphopeptides in surface plasmon resonance studies.
Conclusion/interpretation: Mutations in p85 alpha are uncommon in subjects with syndromes of severe insulin resistance. The Met326Ile p85 alpha variant appears to have no functional effect on the insulin-stimulated phosphoinositide 3-kinase activity. The impaired phosphoinositide 3-kinase activity of the Arg409Gln mutant suggests that it could contribute to the insulin resistance seen in this family.
Similar articles
-
Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome.J Clin Endocrinol Metab. 2000 Feb;85(2):905-18. doi: 10.1210/jcem.85.2.6347. J Clin Endocrinol Metab. 2000. PMID: 10690909
-
A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.J Clin Endocrinol Metab. 2003 Apr;88(4):1468-75. doi: 10.1210/jc.2002-020933. J Clin Endocrinol Metab. 2003. PMID: 12679424
-
Met326Ile aminoacid polymorphism in the human p85 alpha gene has no major impact on early insulin signaling in type 2 diabetes.Horm Metab Res. 2004 Oct;36(10):686-92. doi: 10.1055/s-2004-826024. Horm Metab Res. 2004. PMID: 15523593
-
Genetics of insulin resistance.Exp Clin Endocrinol Diabetes. 1999;107(2):113-8. doi: 10.1055/s-0029-1212085. Exp Clin Endocrinol Diabetes. 1999. PMID: 10320051 Review.
-
Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk.Clin Cancer Res. 2008 Feb 1;14(3):633-7. doi: 10.1158/1078-0432.CCR-07-1211. Clin Cancer Res. 2008. PMID: 18245521 Review.
Cited by
-
Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation.J Biol Chem. 2008 Jun 6;283(23):15861-8. doi: 10.1074/jbc.M800941200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387942 Free PMC article.
-
Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.Cancer Causes Control. 2016 Aug;27(8):965-76. doi: 10.1007/s10552-016-0774-x. Epub 2016 Jun 17. Cancer Causes Control. 2016. PMID: 27314662 Free PMC article.
-
Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5471-6. doi: 10.1073/pnas.0908899107. Epub 2010 Mar 8. Proc Natl Acad Sci U S A. 2010. PMID: 20212113 Free PMC article.
-
Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.Mol Cell Biol. 2004 Feb;24(3):966-75. doi: 10.1128/MCB.24.3.966-975.2004. Mol Cell Biol. 2004. PMID: 14729945 Free PMC article.
-
Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.JCI Insight. 2016 Oct 20;1(17):e88766. doi: 10.1172/jci.insight.88766. JCI Insight. 2016. PMID: 27766312 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous